Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Bryant

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Science Translational Medicine|August 30, 2019
A vaccine-induced gene expression signature correlates with protection against SIV and HIV in multiple trialsPhilip K Ehrenberg, Shida Shangguan, Biju Issac, et al.
Blood|July 13, 2018
Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficienciesCarl E Allen, Rebecca Marsh, Peter Dawson, et al.
Cancer Discovery|October 22, 2020
Selection of Oncogenic Mutant Clones in Normal Human Skin Varies with Body SiteJoanna C Fowler, Charlotte King, Christopher Bryant, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2023
Safety and Immunogenicity of Influenza A/H5N8 Virus Vaccine in Healthy Adults: Durability and Cross-reactivity of Antibody ResponsesKathleen M Neuzil, Evan J Anderson, Robert W Frenck, et al.
The Journal of Infectious Diseases|January 26, 2023
A Multicenter, Controlled Human Infection Study of Influenza A(H1N1)pdm09 in Healthy AdultsJustin R Ortiz, David I Bernstein, Daniel F Hoft, et al.
Vaccine|March 19, 2025
A phase I study of the safety, reactogenicity and immunogenicity of two quadrivalent seasonal influenza vaccines (Fluzone® or Flublok®) with or without one of two adjuvants (AF03 or Advax-CpG55.2) in healthy adults 18-45 years of ageTheresa E Hegmann, Emmanuel B Walter, Michael J Smith, et al.
Plos Pathogens|September 4, 2020
Adjuvanted HIV-1 vaccine promotes antibody-dependent phagocytic responses and protects against heterologous SHIV challengeKier Om, Dominic Paquin-Proulx, Maria Montero, et al.
The Lancet. Microbe|May 18, 2024
SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trialBrittany L Ober Shepherd, Paul T Scott, Jack N Hutter, et al.
Scientific Reports|November 4, 2022
Discovering cell-active BCL6 inhibitors: effectively combining biochemical HTS with multiple biophysical techniques, X-ray crystallography and cell-based assaysOlivier A Pierrat, Manjuan Liu, Gavin W Collie, et al.
Frontiers in Pediatrics|December 12, 2025
Influence of gestational history on neural tube defects and Eisenmenger syndrome: associations with intellectual disability and visual impairment in children and adults - a systematic reviewDianasari, Chamelia Rohadatul 'Aissy, R Mohamad Javier, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Science Translational Medicine|August 30, 2019
A vaccine-induced gene expression signature correlates with protection against SIV and HIV in multiple trialsPhilip K Ehrenberg, Shida Shangguan, Biju Issac, et al.
Blood|July 13, 2018
Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficienciesCarl E Allen, Rebecca Marsh, Peter Dawson, et al.
Cancer Discovery|October 22, 2020
Selection of Oncogenic Mutant Clones in Normal Human Skin Varies with Body SiteJoanna C Fowler, Charlotte King, Christopher Bryant, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2023
Safety and Immunogenicity of Influenza A/H5N8 Virus Vaccine in Healthy Adults: Durability and Cross-reactivity of Antibody ResponsesKathleen M Neuzil, Evan J Anderson, Robert W Frenck, et al.
The Journal of Infectious Diseases|January 26, 2023
A Multicenter, Controlled Human Infection Study of Influenza A(H1N1)pdm09 in Healthy AdultsJustin R Ortiz, David I Bernstein, Daniel F Hoft, et al.
Vaccine|March 19, 2025
A phase I study of the safety, reactogenicity and immunogenicity of two quadrivalent seasonal influenza vaccines (Fluzone® or Flublok®) with or without one of two adjuvants (AF03 or Advax-CpG55.2) in healthy adults 18-45 years of ageTheresa E Hegmann, Emmanuel B Walter, Michael J Smith, et al.
Plos Pathogens|September 4, 2020
Adjuvanted HIV-1 vaccine promotes antibody-dependent phagocytic responses and protects against heterologous SHIV challengeKier Om, Dominic Paquin-Proulx, Maria Montero, et al.
The Lancet. Microbe|May 18, 2024
SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trialBrittany L Ober Shepherd, Paul T Scott, Jack N Hutter, et al.
Scientific Reports|November 4, 2022
Discovering cell-active BCL6 inhibitors: effectively combining biochemical HTS with multiple biophysical techniques, X-ray crystallography and cell-based assaysOlivier A Pierrat, Manjuan Liu, Gavin W Collie, et al.
Frontiers in Pediatrics|December 12, 2025
Influence of gestational history on neural tube defects and Eisenmenger syndrome: associations with intellectual disability and visual impairment in children and adults - a systematic reviewDianasari, Chamelia Rohadatul 'Aissy, R Mohamad Javier, et al.
Pageof 4